Flow cytometric analysis of inflammatory cells in ischemic rat brain.
OBJECTIVE
Inflammation plays a key role in cerebral ischemia through activation of microglia and infiltration by leukocytes. Flow cytometry is a well-established method for quantitative and qualitative analysis of inflammatory cells. However, this technique has not been applied to the study of cerebral ischemia inflammation. The aim of this study was to establish a flow cytometric method to measure inflammatory cells in ischemic brain.


METHODS
To perform flow cytometry on brain tissue, we developed 2 cell-isolation methods based on different mechanical dissociation and Percoll gradient separation techniques. The methods were tested on a rat model of permanent middle cerebral artery occlusion. Morphological and immunophenotypic analyses, with the use of anti-CD11b, anti-CD45, and alphabeta T-cell receptor antibodies, were employed to identify and quantify inflammatory cells.


RESULTS
Both methods gave consistent results in terms of yield and reproducibility. The cell suspension contained granulocytes, macrophages, lymphocytes, and neural cells. Morphological and immunophenotypic analyses enabled the identification of a cell-scatter gate (R1a) enriched in inflammatory cells. With both methods, a higher number of events in R1a were recorded in the ischemic hemisphere than in the nonischemic hemisphere (P< or =0.001). CD11b, CD45, and alphabeta T-cell receptor staining confirmed that this augmentation was a reflection of the increase in the number of granulocytes, cells of the monocytic lineage, and lymphocytes.


CONCLUSIONS
Quantitative flow cytometric analysis of ischemic rat brain is feasible and provides a reliable and rapid assay to assess neuroinflammation in experimental models of brain ischemia.
Campanella
Marilena
M
Schering-Plough Research Institute, Milan, Italy.
Sciorati
Clara
C
Tarozzo
Glauco
G
Beltramo
Massimiliano
M
D000818:Animals; D000918:Antibody Specificity; D001921:Brain / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D002545:Brain Ischemia / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D002452:Cell Count; D002469:Cell Separation; D004195:Disease Models, Animal; D005240:Feasibility Studies; D005434:Flow Cytometry / Q000379:methods*; D016130:Immunophenotyping; D020244:Infarction, Middle Cerebral Artery / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D017493:Leukocyte Common Antigens / Q000096:biosynthesis; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D016177:Macrophage-1 Antigen / Q000096:biosynthesis; D009000:Monocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results
D016177:Macrophage-1 Antigen; D017493:Leukocyte Common Antigens